Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
7162 | 1398 | 30.9 | 62% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
11 | 3 | ATRIAL FIBRILLATION//CARDIAC & CARDIOVASCULAR SYSTEM//CATHETER ABLATION | 130936 |
896 | 2 | AMIODARONE//ANTIARRHYTHMIC DRUGS//PROPAFENONE | 11339 |
7162 | 1 | SOTALOL//DOFETILIDE//CLASS III ANTIARRHYTHMIC AGENT | 1398 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SOTALOL | authKW | 684292 | 7% | 34% | 93 |
2 | DOFETILIDE | authKW | 552058 | 5% | 40% | 63 |
3 | CLASS III ANTIARRHYTHMIC AGENT | authKW | 440425 | 2% | 61% | 33 |
4 | AZIMILIDE | authKW | 378551 | 2% | 67% | 26 |
5 | MS 551 | authKW | 371289 | 1% | 100% | 17 |
6 | D SOTALOL | authKW | 353203 | 2% | 56% | 29 |
7 | CLASS III ANTIARRHYTHMIC DRUGS | authKW | 306101 | 2% | 48% | 29 |
8 | SEMATILIDE | authKW | 294267 | 1% | 84% | 16 |
9 | TEDISAMIL | authKW | 285680 | 2% | 59% | 22 |
10 | CLASS III ANTIARRHYTHMICS | authKW | 278553 | 2% | 51% | 25 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 28756 | 56% | 0% | 782 |
2 | Pharmacology & Pharmacy | 7387 | 43% | 0% | 599 |
3 | Peripheral Vascular Diseases | 726 | 7% | 0% | 103 |
4 | Engineering, Biomedical | 277 | 4% | 0% | 57 |
5 | Chemistry, Medicinal | 216 | 4% | 0% | 62 |
6 | Physiology | 22 | 2% | 0% | 34 |
7 | Toxicology | 14 | 2% | 0% | 25 |
8 | Emergency Medicine | 8 | 1% | 0% | 7 |
9 | Critical Care Medicine | 6 | 1% | 0% | 11 |
10 | Medicine, General & Internal | 6 | 3% | 0% | 40 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANESTHESIOL EXPT PHYSIOL CELLULAIRE E3212 | 43681 | 0% | 100% | 2 |
2 | DIPARTIMENTO MED INTERNA SEZ CARDIOL | 43681 | 0% | 100% | 2 |
3 | ANESTHESIOL CLIN 1MED | 21841 | 0% | 100% | 1 |
4 | ARTERIOSKLEROSIS | 21841 | 0% | 100% | 1 |
5 | CARDIAC UNIT CARDIAC ARRHYTHMIA SERV | 21841 | 0% | 100% | 1 |
6 | CARDIOL 8TH AVE C ST | 21841 | 0% | 100% | 1 |
7 | CARDIOL SECT 691111E | 21841 | 0% | 100% | 1 |
8 | CARDIOLCARDIOL SECT691111E | 21841 | 0% | 100% | 1 |
9 | CARDIOVASC DIS 7243209307 | 21841 | 0% | 100% | 1 |
10 | CENT LIFE SCI | 21841 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 41750 | 10% | 1% | 145 |
2 | CARDIOVASCULAR DRUG REVIEWS | 7465 | 1% | 3% | 12 |
3 | AMERICAN JOURNAL OF CARDIOLOGY | 6861 | 7% | 0% | 92 |
4 | CARDIOVASCULAR RESEARCH | 6648 | 4% | 1% | 49 |
5 | PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 5893 | 4% | 1% | 49 |
6 | CARDIOVASCULAR DRUGS AND THERAPY | 4939 | 2% | 1% | 21 |
7 | JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY | 4611 | 2% | 1% | 30 |
8 | AMERICAN HEART JOURNAL | 4382 | 4% | 0% | 54 |
9 | EUROPEAN HEART JOURNAL | 4323 | 3% | 0% | 45 |
10 | METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY | 2686 | 1% | 1% | 18 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SOTALOL | 684292 | 7% | 34% | 93 | Search SOTALOL | Search SOTALOL |
2 | DOFETILIDE | 552058 | 5% | 40% | 63 | Search DOFETILIDE | Search DOFETILIDE |
3 | CLASS III ANTIARRHYTHMIC AGENT | 440425 | 2% | 61% | 33 | Search CLASS+III+ANTIARRHYTHMIC+AGENT | Search CLASS+III+ANTIARRHYTHMIC+AGENT |
4 | AZIMILIDE | 378551 | 2% | 67% | 26 | Search AZIMILIDE | Search AZIMILIDE |
5 | MS 551 | 371289 | 1% | 100% | 17 | Search MS+551 | Search MS+551 |
6 | D SOTALOL | 353203 | 2% | 56% | 29 | Search D+SOTALOL | Search D+SOTALOL |
7 | CLASS III ANTIARRHYTHMIC DRUGS | 306101 | 2% | 48% | 29 | Search CLASS+III+ANTIARRHYTHMIC+DRUGS | Search CLASS+III+ANTIARRHYTHMIC+DRUGS |
8 | SEMATILIDE | 294267 | 1% | 84% | 16 | Search SEMATILIDE | Search SEMATILIDE |
9 | TEDISAMIL | 285680 | 2% | 59% | 22 | Search TEDISAMIL | Search TEDISAMIL |
10 | CLASS III ANTIARRHYTHMICS | 278553 | 2% | 51% | 25 | Search CLASS+III+ANTIARRHYTHMICS | Search CLASS+III+ANTIARRHYTHMICS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | FITTON, A , SORKIN, EM , (1993) SOTALOL - AN UPDATED REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN CARDIAC-ARRHYTHMIAS.DRUGS. VOL. 46. ISSUE 4. P. 678 -719 | 139 | 70% | 42 |
2 | CLAUDEL, JP , TOUBOUL, P , (1995) SOTALOL - FROM JUST ANOTHER BETA-BLOCKER TO THE PROTOTYPE OF CLASS-III ANTIDYSRHYTHMIC COMPOUND.PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY. VOL. 18. ISSUE 3. P. 451-467 | 68 | 88% | 16 |
3 | NAIR, LA , GRANT, AO , (1997) EMERGING CLASS III ANTIARRHYTHMIC AGENTS: MECHANISM OF ACTION AND PROARRHYTHMIC POTENTIAL.CARDIOVASCULAR DRUGS AND THERAPY. VOL. 11. ISSUE 2. P. 149-167 | 62 | 56% | 45 |
4 | HOHNLOSER, SH , WOOSLEY, RL , (1994) DRUG-THERAPY - SOTALOL.NEW ENGLAND JOURNAL OF MEDICINE. VOL. 331. ISSUE 1. P. 31-38 | 48 | 70% | 123 |
5 | MOUNSEY, JP , DIMARCO, JP , (2000) DOFETILIDE.CIRCULATION. VOL. 102. ISSUE 21. P. 2665 -2670 | 37 | 73% | 47 |
6 | FUNCKBRENTANO, C , (1993) PHARMACOKINETIC AND PHARMACODYNAMIC PROFILES OF D-SOTALOL AND D,L-SOTALOL.EUROPEAN HEART JOURNAL. VOL. 14. ISSUE . P. 30-35 | 37 | 93% | 20 |
7 | ANDERSON, JL , PRYSTOWSKY, EN , (1999) SOTALOL: AN IMPORTANT NEW ANTIARRHYTHMIC.AMERICAN HEART JOURNAL. VOL. 137. ISSUE 3. P. 388 -409 | 39 | 64% | 51 |
8 | COLATSKY, TJ , ARGENTIERI, TM , (1994) POTASSIUM CHANNEL BLOCKERS AS ANTIARRHYTHMIC DRUGS.DRUG DEVELOPMENT RESEARCH. VOL. 33. ISSUE 3. P. 235 -249 | 39 | 75% | 39 |
9 | FALK, RH , DECARA, JM , (2000) DOFETILIDE: A NEW PURE CLASS III ANTIARRHYTHMIC AGENT.AMERICAN HEART JOURNAL. VOL. 140. ISSUE 5. P. 697 -706 | 32 | 76% | 15 |
10 | KALUS, JS , MAURO, VF , (2000) DOFETILIDE: A CLASS III-SPECIFIC ANTIARRHYTHMIC AGENT.ANNALS OF PHARMACOTHERAPY. VOL. 34. ISSUE 1. P. 44 -56 | 31 | 78% | 8 |
Classes with closest relation at Level 1 |